Heart Center Brandenburg, Department of Cardiovascular Surgery, University Hospital Brandenburg Medical School "Theodor Fontane", Bernau, Germany.
Surg Technol Int. 2021 Nov 4;39:313-316. doi: 10.52198/21.STI.39.CV1504.
Disturbed wound healing is a significant problem in patients after cardiac surgery. Problems with deep sternal wound healing are rare, but can be quite difficult to treat. Furthermore, the therapy is highly expensive and consumes many of the patient's personal resources. Another major obstacle in this patient group is reinfection after secondary wound closure. We examined how to prevent early reinfection through the use of growth factors in combination with local antibiotics.
Our study included 232 patients with a deep sternal wound healing problem. After initial vacuum therapy, we planned secondary wound closure. During wound closure, we used only platelet-rich fibrin in a PRF group (109 patients). In another group (123 patients), we covered the wounds intraoperatively with a combination of PRF and local antibiotics (PRF CoDelivery). All patients were observed for 30 days for signs of early surgical site infection.
After 30 days, 22 patients (20.2%) in the PRF group showed a persistent problem with wound healing with or without reinfection. In contrast, only 12 patients (9.8%) in the PRF CoDelivery group had this problem (p=0.023 PRF vs. PRF CoDelivery).
The combination of growth factors and antibiotics was associated with a significantly reduced incidence of early reinfection and thus can be expected to have a positive impact on wound healing in complicated scenarios. Furthermore, the combination of PRF and local antibiotics was easy to use. Further studies are needed to verify these initial findings.
心脏手术后患者的创面愈合不良是一个重大问题。胸骨深部愈合不良较为罕见,但治疗难度较大。此外,治疗费用高昂,会消耗患者大量的个人资源。对于该患者群体,另一个主要障碍是二期缝合后再次感染。我们研究了如何通过使用生长因子联合局部抗生素来预防早期再感染。
我们的研究纳入了 232 例胸骨深部愈合不良的患者。在初次负压治疗后,我们计划进行二期缝合。在缝合过程中,我们仅在富血小板纤维蛋白(PRF)组(109 例)中使用富含血小板的纤维蛋白。在另一组(123 例)中,我们在术中使用 PRF 联合局部抗生素覆盖伤口(PRF 共递送组)。所有患者均观察 30 天,以发现早期手术部位感染的迹象。
30 天后,PRF 组中有 22 例(20.2%)患者出现持续的愈合问题,伴或不伴再感染。相比之下,PRF CoDelivery 组中只有 12 例(9.8%)患者出现该问题(PRF 与 PRF CoDelivery 相比,p=0.023)。
生长因子和抗生素的联合应用与早期再感染发生率的显著降低相关,因此有望对复杂情况下的创面愈合产生积极影响。此外,PRF 与局部抗生素联合应用易于操作。需要进一步的研究来验证这些初步发现。